Lead Product(s) : Rabies Immune Globulin (Human)
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Kedrion
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The study of KEDRAB® (Rabies Immune Globulin [Human]) conducted in children was the first and only pediatric study for any HRIG available in U.S. The study met its primary objective, which was to confirm the safety of KEDRAB in the pediatric population.
Product Name : Kedrab
Product Type : Vaccine
Upfront Cash : Inapplicable
August 19, 2020
Lead Product(s) : Rabies Immune Globulin (Human)
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Kedrion
Deal Size : Inapplicable
Deal Type : Inapplicable